Avotaciclib
Avotaciclib (BEY1107) is an orally bioavailable, potent inhibitor of cyclin-dependent kinase 1 (CDK1) . It is a research compound used in preclinical studies, including in vitro and in vivo models, to investigate therapeutic strategies for cancers such as locally advanced or metastatic pancreatic adenocarcinoma.
Product Specifications
CAS Number
1983983-41-0
Product Name Alternative
CDK1, BEY1107, BEY 1107, BEY-1107, Avotaciclib
Field of Research
Cell Biology
Purity
97.98% (May vary between batches)
Solubility
DMSO:50 mg/mL (177.77 mM)
Smiles
OC1=C (N=C (C=C1) C2=NC (N) =NC=C2) C3=NC (N) =NC=C3
Molecular Formula
C13H11N7O
Molecular Weight
281.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
103311F2-AAT 500 Tests
APC/iFluor® 700 Anti-human CD33 Antibody *HIM3-4*
Sign In for Pricing
View Details 
